Colombia vs Senegal: The number of people with susceptibility test result for rifampicin
Colombia
3,134
in 2021
Senegal
3,191
in 2021
Colombia rank
39th
Senegal rank
38th
The number of people with susceptibility test result for rifampicin over time
- Colombia
- Senegal
How they compare
Senegal currently reports 3,191 against 3,134 in Colombia, a difference of 57.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Senegal ahead.
Colombia ranks 39th and Senegal ranks 38th of 155 countries.
Senegal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Colombia | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,906 | 2,385 | 479.67 | Senegal |
| 2020s | 2,255 | 2,388 | 133.5 | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Colombia or Senegal?
- Senegal, at 3,191 against 3,134 in Colombia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Colombia and Senegal?
- 57, with Senegal ahead.
- How many years of comparable data are there for Colombia and Senegal?
- 5 years are reported by both, from 2017 to 2021.
- How do Colombia and Senegal rank globally for the number of people with susceptibility test result for rifampicin?
- Colombia ranks 39th and Senegal ranks 38th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.